Illumina Net Income
| ILMN Stock | USD 134.46 7.06 5.54% |
As of the 28th of February, Illumina retains the Market Risk Adjusted Performance of (0.77), downside deviation of 2.62, and Risk Adjusted Performance of 0.0535. Illumina technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Illumina Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 4.6971 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 850 M | 892.5 M | |
| Net Income Applicable To Common Shares | 850 M | 892.5 M | |
| Net Income From Continuing Ops | 850 M | 892.5 M | |
| Net Loss | (7.35) | (6.98) | |
| Net Income Per E B T | 1.04 | 0.66 |
Illumina | Net Income | Build AI portfolio with Illumina Stock |
Evaluating Illumina's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Illumina's fundamental strength.
Latest Illumina's Net Income Growth Pattern
Below is the plot of the Net Income of Illumina over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Illumina financial statement analysis. It represents the amount of money remaining after all of Illumina operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Illumina's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Illumina's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 850 M | 10 Years Trend |
|
Net Income |
| Timeline |
Illumina Net Income Regression Statistics
| Arithmetic Mean | 33,043,021 | |
| Geometric Mean | 442,981,752 | |
| Coefficient Of Variation | 3,972 | |
| Mean Deviation | 814,787,027 | |
| Median | 461,559,000 | |
| Standard Deviation | 1,312,482,129 | |
| Sample Variance | 1722609.3T | |
| Range | 5.4B | |
| R-Value | (0.18) | |
| Mean Square Error | 1774584.5T | |
| R-Squared | 0.03 | |
| Significance | 0.48 | |
| Slope | (48,075,240) | |
| Total Sum of Squares | 27561749.4T |
Illumina Net Income History
Other Fundumenentals of Illumina
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Illumina Net Income component correlations
Illumina Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Illumina is extremely important. It helps to project a fair market value of Illumina Stock properly, considering its historical fundamentals such as Net Income. Since Illumina's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Illumina's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Illumina's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Life Sciences Tools & Services sector continue expanding? Could Illumina diversify its offerings? Factors like these will boost the valuation of Illumina. Market participants price Illumina higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Illumina data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.864 | Earnings Share 5.45 | Revenue Per Share | Quarterly Revenue Growth 0.05 | Return On Assets |
Illumina's market price often diverges from its book value, the accounting figure shown on Illumina's balance sheet. Smart investors calculate Illumina's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Illumina's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Illumina 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Illumina's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Illumina.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Illumina on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Illumina or generate 0.0% return on investment in Illumina over 90 days. Illumina is related to or competes with Quest Diagnostics, Waters, Medpace Holdings, Zimmer Biomet, Hologic, Tenet Healthcare, and ICON PLC. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis More
Illumina Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Illumina's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Illumina upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.62 | |||
| Information Ratio | 0.0263 | |||
| Maximum Drawdown | 15.59 | |||
| Value At Risk | (3.26) | |||
| Potential Upside | 4.09 |
Illumina Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Illumina's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Illumina's standard deviation. In reality, there are many statistical measures that can use Illumina historical prices to predict the future Illumina's volatility.| Risk Adjusted Performance | 0.0535 | |||
| Jensen Alpha | 0.1639 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.0262 | |||
| Treynor Ratio | (0.78) |
Illumina February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0535 | |||
| Market Risk Adjusted Performance | (0.77) | |||
| Mean Deviation | 2.0 | |||
| Semi Deviation | 2.43 | |||
| Downside Deviation | 2.62 | |||
| Coefficient Of Variation | 1646.79 | |||
| Standard Deviation | 2.61 | |||
| Variance | 6.82 | |||
| Information Ratio | 0.0263 | |||
| Jensen Alpha | 0.1639 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.0262 | |||
| Treynor Ratio | (0.78) | |||
| Maximum Drawdown | 15.59 | |||
| Value At Risk | (3.26) | |||
| Potential Upside | 4.09 | |||
| Downside Variance | 6.85 | |||
| Semi Variance | 5.93 | |||
| Expected Short fall | (2.21) | |||
| Skewness | (0.69) | |||
| Kurtosis | 2.85 |
Illumina Backtested Returns
As of now, Illumina Stock is very steady. Illumina holds Efficiency (Sharpe) Ratio of 0.0401, which attests that the entity had a 0.0401 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Illumina, which you can use to evaluate the volatility of the firm. Please check out Illumina's Risk Adjusted Performance of 0.0535, downside deviation of 2.62, and Market Risk Adjusted Performance of (0.77) to validate if the risk estimate we provide is consistent with the expected return of 0.11%. Illumina has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.19, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Illumina are expected to decrease at a much lower rate. During the bear market, Illumina is likely to outperform the market. Illumina right now retains a risk of 2.67%. Please check out Illumina semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if Illumina will be following its current trending patterns.
Auto-correlation | -0.53 |
Good reverse predictability
Illumina has good reverse predictability. Overlapping area represents the amount of predictability between Illumina time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Illumina price movement. The serial correlation of -0.53 indicates that about 53.0% of current Illumina price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.53 | |
| Spearman Rank Test | -0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 192.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Illumina Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Illumina reported net income of 850 M. This is 149.06% higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 48.87% lower than that of the firm.
Illumina Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Illumina's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Illumina could also be used in its relative valuation, which is a method of valuing Illumina by comparing valuation metrics of similar companies.Illumina is currently under evaluation in net income category among its peers.
Illumina ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Illumina's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Illumina's managers, analysts, and investors.Environmental | Governance | Social |
Illumina Institutional Holders
Institutional Holdings refers to the ownership stake in Illumina that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Illumina's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Illumina's value.| Shares | Bank Of New York Mellon Corp | 2025-06-30 | 2.3 M | Guardcap Asset Management Limited | 2025-06-30 | 2 M | Primecap Management Company | 2025-06-30 | 2 M | Bank Of America Corp | 2025-06-30 | 1.9 M | Hhg Plc | 2025-06-30 | 1.9 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1.8 M | Baillie Gifford & Co Limited. | 2025-06-30 | 1.7 M | Northern Trust Corp | 2025-06-30 | 1.6 M | Edmond De Rothschild Holding S.a. | 2025-06-30 | 1.4 M | Blackrock Inc | 2025-06-30 | 19.4 M | Capital World Investors | 2025-06-30 | 16.6 M |
Illumina Fundamentals
| Return On Equity | 0.33 | ||||
| Return On Asset | 0.0839 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 20.4 B | ||||
| Shares Outstanding | 152.9 M | ||||
| Shares Owned By Insiders | 0.43 % | ||||
| Shares Owned By Institutions | 99.57 % | ||||
| Number Of Shares Shorted | 7.92 M | ||||
| Price To Earning | 49.12 X | ||||
| Price To Book | 7.15 X | ||||
| Price To Sales | 4.73 X | ||||
| Revenue | 4.34 B | ||||
| Gross Profit | 2.96 B | ||||
| EBITDA | 1.46 B | ||||
| Net Income | 850 M | ||||
| Cash And Equivalents | 1.42 B | ||||
| Cash Per Share | 6.62 X | ||||
| Total Debt | 2.55 B | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 0.93 X | ||||
| Book Value Per Share | 17.80 X | ||||
| Cash Flow From Operations | 1.08 B | ||||
| Short Ratio | 3.34 X | ||||
| Earnings Per Share | 5.45 X | ||||
| Price To Earnings To Growth | 0.62 X | ||||
| Target Price | 136.05 | ||||
| Number Of Employees | 8.6 K | ||||
| Beta | 1.45 | ||||
| Market Capitalization | 20.56 B | ||||
| Total Asset | 6.64 B | ||||
| Retained Earnings | (392 M) | ||||
| Working Capital | 1.7 B | ||||
| Current Asset | 2.1 B | ||||
| Current Liabilities | 610.49 M | ||||
| Net Asset | 6.64 B |
About Illumina Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Illumina's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Illumina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Illumina based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Illumina
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.Moving against Illumina Stock
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Will Life Sciences Tools & Services sector continue expanding? Could Illumina diversify its offerings? Factors like these will boost the valuation of Illumina. Market participants price Illumina higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Illumina data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.864 | Earnings Share 5.45 | Revenue Per Share | Quarterly Revenue Growth 0.05 | Return On Assets |
Illumina's market price often diverges from its book value, the accounting figure shown on Illumina's balance sheet. Smart investors calculate Illumina's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Illumina's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.